A team of researchers from Toho University has uncovered a potential new use for a naturally occurring compound, schisandrin A, found in the traditional Chinese medicinal plant Schisandra chinensis.
Preclinical data support CRAC channel inhibitor, CM5480, as a potential first-in-class, differentiated therapy for pulmonary arterial hypertension (PAH), both as monotherapy and in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback